Advancing Prostate Cancer Staging: A Single-Step Approach With Bi-parametric and Whole-Body Diffusion MRI in an African Cohort

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 5; p. e59470
• Main Authors: Asafu Adjaye Frimpong, George, Aboagye, Evans, Asante, Emmanuel, Appiah, Kwaku Addai A, Owusu-Afriyie, Osei, Asare, Adwoa O, Atuobi, Dorcas, Akpaloo, Bernard D, Antwi, Bright
• Format: Journal Article
• Language: English
• Published: United States 01.05.2024
• Subjects: whole-body diffusion-weighted mri; biparametric mri; prostate cancer; staging; african men
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.59470

 To document our initial experience using whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) and bi-parametric magnetic resonance imaging (bpMRI) as a single exam in the staging of biopsy-proven prostate cancers. This retrospective study involved 120 African men with biopsy-confirmed prostate cancer (PCa). All the participants had a single exam that included both a bpMRI and a WB-DWI/MRI. The results were analyzed based on the American Urological Association's risk stratification system and evaluated using descriptive statistics. The combined imaging approach confirmed PCa in all cases, identifying pelvic lymph node metastases in 21 (17.5%) patients. Among 72 high-risk patients, bpMRI+WB-DWI/MRI detected pelvic lymph node metastases in 18 (25.0%), bone metastases in 15 (20.8%), retroperitoneal lymph node metastases in six (8.3%), and extraprostatic extension in 18 (25%), with no solid organ metastases observed. The combination of WB-DWI/MRI and bpMRI in a single-step approach demonstrates diagnostic potential in primary prostate cancer staging for high-risk groups, with the added advantage of shorter examination times, lower patients' costs, and elimination of the risks of adverse events associated with the use of contrast agents and exposure to radiation.